Corporate and Other comprises administrative expenses for central Group functions that cannot be directly allocated to the business sectors.
Key figures |
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
Change |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
€ million |
|
2025 |
|
2024 |
|
€ million |
|
% |
||||||
Operating result (EBIT)1 |
|
-413 |
|
-702 |
|
289 |
|
-41.2% |
||||||
EBITDA2 |
|
-291 |
|
-584 |
|
293 |
|
-50.2% |
||||||
EBITDA pre1 |
|
-388 |
|
-482 |
|
94 |
|
-19.4% |
||||||
|
||||||||||||||
In particular, the improvement in the operating result and EBITDA in fiscal 2025 in comparison with the previous year was attributable to other operating income from realized gains from currency translation due to an absolute reduction of the share in a foreign business operation, with the corresponding reclassification of the pro rata accumulated currency translation difference. When adjusted for this income, EBITDA pre also improved compared with the previous year. Income from non-income taxes due to changes in legislation in Latin America also had a favorable impact on earnings in all three key performance indicators. These positive effects were partly offset by higher ongoing administrative expenses. Cross-business research and development costs amounting to € 62 million (2024: € 92 million) were allocated to Corporate and Other.